According to Gram Research analysis, low-intensity ultrasound applied to the liver delayed diabetic cataract development in rats by reducing blood sugar, lowering harmful amino acids, and restoring a protective protein in eye lens cells. The treatment prevented the cellular damage that causes cataracts while improving liver and pancreas health without causing tissue damage. This non-invasive approach suggests a new preventive strategy for diabetic eye complications, though human studies are still needed.
Researchers discovered that a special type of ultrasound applied to the liver could prevent or slow down cataracts caused by diabetes. In studies with diabetic rats, this gentle ultrasound treatment reduced blood sugar levels, changed harmful amino acids in the blood, and protected the lens of the eye from clouding over. The treatment worked by helping the liver communicate better with the eye through a specific protein. This non-surgical approach could offer people with diabetes a new way to prevent vision problems before they start, rather than waiting for surgery.
Key Statistics
A 2026 research article published in Biochimica et Biophysica Acta found that 30 days of daily liver-targeted low-intensity ultrasound (200 mW/cm² for 10 minutes) significantly delayed cataract onset and progression in type 2 diabetic rats compared to untreated diabetic controls.
The ultrasound treatment reduced branched-chain amino acid (BCAA) levels in both the liver and serum of diabetic rats while restoring PRKAR1A protein expression in lens epithelial cells, a key mechanism preventing the cellular transformation that causes cataracts.
In laboratory studies, removing the PRKAR1A protein completely reversed the protective effects of liver-targeted ultrasound on lens epithelial cells, demonstrating this protein is essential to how the treatment prevents cataract formation.
The liver-targeted ultrasound improved pancreatic and hepatic tissue health in diabetic rats without causing detectable tissue damage, suggesting the treatment is safe and may benefit overall metabolic function beyond eye protection.
The Quick Take
- What they studied: Whether gentle ultrasound waves directed at the liver could prevent or slow the clouding of the eye lens (cataracts) that happens in people with diabetes
- Who participated: Laboratory rats with type 2 diabetes created by feeding them a high-fat diet and giving them a chemical that damages the pancreas, plus normal rats as a comparison group
- Key finding: Rats that received 10 minutes of liver ultrasound daily for 30 days showed delayed cataract development, lower blood sugar, reduced harmful amino acids, and better eye lens protection compared to untreated diabetic rats
- What it means for you: This research suggests a potential new preventive tool for people with diabetes to protect their vision before cataracts develop, though human studies are still needed to confirm safety and effectiveness
The Research Details
Scientists created a realistic model of type 2 diabetes in laboratory rats by feeding them a high-fat diet combined with a chemical injection that damages insulin-producing cells. They then divided the rats into three groups: healthy rats (control), diabetic rats without treatment (model), and diabetic rats receiving the experimental ultrasound therapy. The ultrasound treatment was gentle and focused—200 milliwatts per square centimeter directed at the liver for just 10 minutes each day over 30 days. This is similar to how ultrasound is used in medical imaging, but at lower intensity and with a specific therapeutic purpose.
The researchers measured multiple outcomes to understand how the treatment worked. They examined the rats’ eyes using a special microscope to see if cataracts were forming. They also measured blood sugar levels, checked specific amino acids in the blood and liver, and looked at protein expression in eye lens cells. In addition to animal studies, they grew liver and eye cells together in laboratory dishes to understand the communication between these organs and tested what happened when they removed a specific protein called PRKAR1A.
This research approach is important because it tests a completely different strategy than current diabetes eye care. Instead of waiting for cataracts to form and then surgically removing them, this method targets the root causes—high blood sugar and harmful metabolic changes—before they damage the eye. By studying the liver-to-eye connection, researchers identified a new pathway for prevention that could eventually help millions of people with diabetes keep their vision longer.
This is laboratory research in animals, which is an important early step but not yet proof that the treatment works in humans. The study used standard scientific methods including proper control groups, statistical analysis, and multiple measurements to verify results. The research was published in a peer-reviewed scientific journal, meaning other experts reviewed it before publication. However, animal studies don’t always translate directly to humans, so human clinical trials would be needed before this could become a medical treatment.
What the Results Show
The ultrasound treatment successfully delayed when cataracts started to form and slowed their progression in diabetic rats. Rats receiving the liver ultrasound showed significantly lower blood sugar levels compared to untreated diabetic rats, suggesting the treatment improved the body’s ability to control glucose. The treatment also reduced levels of specific amino acids called branched-chain amino acids (BCAAs) in both the liver and bloodstream—these amino acids are thought to contribute to cataract formation in diabetes.
Most importantly, the ultrasound restored a protein called PRKAR1A in the lens cells of the eye. This protein appears to be a key protector against the cellular changes that lead to cataracts. The treatment prevented a harmful process called epithelial-mesenchymal transition (EMT), which is when lens cells lose their normal structure and function. When researchers removed the PRKAR1A protein in laboratory experiments, the protective effect of ultrasound disappeared, proving this protein is essential to how the treatment works.
Beyond eye protection, the ultrasound improved the health of liver and pancreas tissue in the diabetic rats without causing any detectable damage. This suggests the treatment is safe and may have broader benefits for overall metabolic health in diabetes.
The research revealed that the liver and eye communicate through a specific biological pathway. By improving liver function and reducing harmful amino acid production in the liver, the treatment indirectly protected the eye lens. This ’liver-to-lens axis’ represents a new way of thinking about diabetic eye complications—not just as a local eye problem, but as part of a whole-body metabolic disorder that can be addressed through liver-targeted therapy.
Current diabetes eye care focuses almost entirely on managing blood sugar and surgically removing cataracts once they form. This research builds on growing evidence that the liver plays a central role in diabetes complications and suggests that targeting the liver could prevent multiple complications at once. Previous studies have shown that branched-chain amino acids are elevated in diabetes and linked to complications, but this is the first research to show that reducing them through liver-targeted ultrasound can prevent cataracts specifically.
This study was conducted entirely in laboratory rats with artificially induced diabetes, not in humans with naturally occurring type 2 diabetes. The exact dose and delivery method that would work in humans is unknown. The study doesn’t tell us whether the benefits would last long-term or what happens if treatment stops. Additionally, the mechanism discovered in rats may not work identically in humans due to differences in metabolism and physiology. Before this could become a medical treatment, researchers would need to conduct careful human clinical trials to confirm safety and effectiveness.
The Bottom Line
Based on this research, low-intensity liver-targeted ultrasound shows promise as a preventive strategy for diabetic cataracts. However, this is early-stage research in animals. Current evidence-based recommendations for people with diabetes remain: maintain tight blood sugar control, manage blood pressure, avoid smoking, wear UV-protective sunglasses, and have regular eye exams. This ultrasound approach may eventually complement these strategies, but it is not yet available as a clinical treatment.
This research is most relevant to people with type 2 diabetes who are concerned about vision loss, researchers studying diabetes complications, and eye care specialists looking for preventive approaches. It’s less immediately relevant to people with type 1 diabetes or those without diabetes. Anyone interested in this treatment should wait for human clinical trials before considering it, as it remains experimental.
In the rat studies, protective effects appeared within 30 days of treatment. However, human studies would need to run much longer—likely months to years—to determine if similar benefits occur and how long they last. If human trials eventually prove successful, it could take 5-10 years before this becomes available as a medical treatment.
Frequently Asked Questions
Can ultrasound treatment prevent cataracts in people with diabetes?
This research shows promise in diabetic rats, but human studies haven’t been conducted yet. The treatment delayed cataract development by improving blood sugar control and reducing harmful amino acids, but it remains experimental and not available as a medical treatment.
How does liver ultrasound protect the eyes from diabetes damage?
The liver produces branched-chain amino acids that contribute to cataract formation. Ultrasound reduces these amino acids and restores a protective protein (PRKAR1A) in eye lens cells, preventing the cellular damage that causes clouding. It’s a liver-to-eye communication pathway.
Is low-intensity ultrasound safe for treating diabetes complications?
In this rat study, 30 days of daily liver ultrasound improved tissue health without causing damage. However, safety in humans hasn’t been tested yet. Any new medical treatment requires careful human clinical trials before it can be recommended.
What should people with diabetes do now to prevent cataracts?
Current proven strategies include maintaining tight blood sugar control, managing blood pressure, avoiding smoking, wearing UV-protective sunglasses, and having regular eye exams. This ultrasound research is promising but experimental—continue following your doctor’s current recommendations.
When will this ultrasound treatment be available for patients?
This is early-stage research. Human clinical trials would need to be conducted first, which typically takes 5-10 years. If successful, regulatory approval would follow. It’s not yet available as a medical treatment.
Want to Apply This Research?
- Track blood sugar readings, eye health appointments, and any vision changes in a diabetes management app. Users could log daily glucose levels and set reminders for annual eye exams to monitor for early cataract signs.
- Users could set app reminders to maintain consistent blood sugar control through diet and medication, as this research reinforces that good glucose management protects eye health. They could also track lifestyle factors that improve liver health, such as reducing alcohol intake and maintaining a healthy weight.
- Create a long-term monitoring dashboard that tracks blood sugar trends, liver health markers (if available through testing), and vision quality over time. Users could photograph their eyes periodically or log any vision changes to share with their eye doctor, helping catch early cataract development.
This research is from animal studies and has not been tested in humans. It describes experimental findings that are not yet available as a medical treatment. People with diabetes should continue following their doctor’s current recommendations for eye health, including regular eye exams, blood sugar management, and UV protection. Do not attempt to use ultrasound therapy for cataracts outside of approved clinical trials. Always consult with your eye care specialist and endocrinologist before making changes to your diabetes management plan. This article is for educational purposes and should not be considered medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.